Search hospitals > Texas > Fort Worth
Texas Oncology-Fort Worth Cancer Center
Claim this profileFort Worth, Texas 76104
Global Leader in Cancer
Global Leader in Ovarian Cancer
Conducts research for Breast Cancer
Conducts research for Ovarian Tumors
Conducts research for Lung Cancer
98 reported clinical trials
5 medical researchers
Summary
Texas Oncology-Fort Worth Cancer Center is a medical facility located in Fort Worth, Texas. This center is recognized for care of Cancer, Ovarian Cancer, Breast Cancer, Ovarian Tumors, Lung Cancer and other specialties. Texas Oncology-Fort Worth Cancer Center is involved with conducting 98 clinical trials across 102 conditions. There are 5 research doctors associated with this hospital, such as Noelle Cloven, MD, Stephen Richey, Chi M Pham, and Harris Naina, MD.Area of expertise
1Cancer
Global LeaderStage III
Stage IV
BRCA2 positive
2Ovarian Cancer
Global LeaderStage IV
BRCA1 positive
BRCA2 positive
Top PIs
Noelle Cloven, MDTexas Oncology-Fort Worth Cancer Center4 years of reported clinical research
Expert in Ovarian Cancer
Studies Ovarian Tumors
21 reported clinical trials
39 drugs studied
Stephen RicheyTexas Oncology - Fort Worth5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Colorectal Cancer
8 reported clinical trials
17 drugs studied
Chi M PhamUSO - Texas Oncology3 years of reported clinical research
Studies Breast Cancer
Studies Cancer
3 reported clinical trials
9 drugs studied
Harris Naina, MDTexas Oncology - Fort Worth3 years of reported clinical research
Studies Lymphoma
Studies B-Cell Lymphoma
3 reported clinical trials
14 drugs studied
Clinical Trials running at Texas Oncology-Fort Worth Cancer Center
Breast Cancer
Prostate Cancer
Endometrial Cancer
Ovarian Cancer
Cancer
Ovarian Tumors
Pancreatic Cancer
Bladder Cancer
Lymphoma
Small Cell Lung Cancer
Zanidatamab vs Trastuzumab
for Breast Cancer
The efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will be evaluated for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previous T-DXd treatment.
Recruiting2 awards Phase 34 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
NUV-868 + Olaparib/Enzalutamide
for Cancer
This trial tests a new drug, NUV-868, taken regularly by mouth, in patients with advanced cancers. It aims to find the best dose and see if combining it with other drugs can improve treatment. The study includes patients with advanced solid tumors and a specific type of prostate cancer.
Recruiting1 award Phase 1 & 211 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Texas Oncology-Fort Worth Cancer Center?
Texas Oncology-Fort Worth Cancer Center is a medical facility located in Fort Worth, Texas. This center is recognized for care of Cancer, Ovarian Cancer, Breast Cancer, Ovarian Tumors, Lung Cancer and other specialties. Texas Oncology-Fort Worth Cancer Center is involved with conducting 98 clinical trials across 102 conditions. There are 5 research doctors associated with this hospital, such as Noelle Cloven, MD, Stephen Richey, Chi M Pham, and Harris Naina, MD.